Overview
Shigeyuki Morino practices practicing medicine in Sasebo, Japan.
His clinical expertise encompasses Squamous Cell Lung Carcinoma, Lung Cancer, and Colorectal Cancer.
He is actively involved in clinical research, co-authoring 13 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Shigeyuki Morino
Is Shigeyuki Morino a top-rated expert for Squamous Cell Lung Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Shigeyuki Morino is classified as an Experienced expert for Squamous Cell Lung Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Shigeyuki Morino participate in research or clinical trials?
Yes. Shigeyuki Morino has published 13 articles and abstracts on conditions like Squamous Cell Lung Carcinoma. You can view a list of Shigeyuki Morino's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Colorectal CancerMr. Morino isExperienced. Learn about Colorectal Cancer.
- Lung CancerMr. Morino isExperienced. Learn about Lung Cancer.
- Squamous Cell Lung CarcinomaMr. Morino isExperienced. Learn about Squamous Cell Lung Carcinoma.